FDA panel backs NPS Pharmaceuticals (NPSP) Gattex
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Jefferies Raises NPS Pharmaceuticals (NPSP) Target to $15 after FDA Panel Backing
October 17, 2012 7:19 AM EDTJefferies lifted its price target on Buy-rated NPS Pharmaceuticals Inc. (NASDAQ: NPSP) from $13 to $15 following FDA panel backing of Gattex.
"As expected, FDA's AdComm panel voted for recommending approval of Gattex unanimously. Panel also voted favorably on NPSP's proposed REMS (10-1), supporting likely timely... More
NPS Pharmaceuticals (NPSP) Mildly Higher after FDA Backing
October 16, 2012 4:21 PM EDTNPS Pharmaceuticals, Inc. (NASDAQ: NPSP) resumes after FDA panel backing for Gattex. Shares are currently up about 1% to $10.29.... More
NPS Pharmaceuticals (NPSP) to resume trading at 4:20PM
October 16, 2012 4:19 PM EDTNPS Pharmaceuticals, Inc. (NASDAQ: NPSP) to resume trading at 4:20PM after FDA panel backing for Gattex.... More
